Video

PNH Treatment Update

Author(s):

Aplastic Anemia,MDS International Foundation

Dr. Antonio Risitano, a hematologist from the University of Naples, discusses the most current thinking on PNH and its treatment.

Dr. Antonio Risitano, a hematologist from the University of Naples, discusses the most current thinking on PNH and its treatment. Topics include an overview of PNH, recent developments in diagnosis and treatment, and the future of treatments.

Related Videos
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Christine N. Kay, MD | Image Credit: Atsena Therapeutics
Christine N. Kay, MD: Interim Data on ATSN-201 Shows Promise for XLRS | Image Credit: Vitreo Retinal Associates
Roger A. Goldberg, MD: Pooled Visual Function Data of NT-501 for MacTel | Image Credit: Bay Area Retina Associates
Signs and Symptoms of Connective Tissue Disease
How Gene and Cell Therapy Is Developing in Dermatology
Joyce Teng, MD, PhD, discusses how therapeutic advances in fields like epidermolysis bullosa should progress treatment discourse in other rare dermatoses.
The Prospect of Pz-cel in RDEB Treatment, with Peter Marinkovich, MD
Related Content
AND017 Receives FDA Orphan Drug Designation for Sickle Cell Disease | Image Credit: US Food and Drug Administration
October 25th 2024

AND017 Receives FDA Orphan Drug Designation for Sickle Cell Disease

Connor Iapoce
New Insight with Veeral Sheth, MD Podcast logo | Image Credit: HCPLive
July 2nd 2024

New Insight: A Look at Gildeuretinol (ALK-001) for Stargardt Disease w/ Seemi Khan, MD

Connor Iapoce
OCU400 Appears Safe, Effective for Retinitis Pigmentosa in Phase 1/2 Update | Image Credit: University of Miami
October 18th 2024

OCU400 Appears Safe, Effective for Retinitis Pigmentosa in Phase 1/2 Update

Connor Iapoce
Autoimmune Hepatitis at ACG 2023, with Gina Choi, MD
October 25th 2023

Autoimmune Hepatitis at ACG 2023, with Gina Choi, MD

Kevin Kunzmann
Ophthalmology Month in Review: September 2024 | Image Credit: HCPLive
October 8th 2024

Ophthalmology Month in Review: September 2024

Connor Iapoce
TransCon hGH Aims for FDA Label Expansion for Adult Growth Hormone Deficiency| Image Credit: US Food and Drug Administration
September 30th 2024

TransCon hGH Aims for FDA Label Expansion for Adult Growth Hormone Deficiency

Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.